![Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design - Richard Nicholas, Sebastian Straube, Heinz Schmidli, Simon Schneider, Tim Friede, 2011 Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design - Richard Nicholas, Sebastian Straube, Heinz Schmidli, Simon Schneider, Tim Friede, 2011](https://journals.sagepub.com/cms/10.1177/1352458511406309/asset/images/large/10.1177_1352458511406309-fig2.jpeg)
Trends in annualized relapse rates in relapsing–remitting multiple sclerosis and consequences for clinical trial design - Richard Nicholas, Sebastian Straube, Heinz Schmidli, Simon Schneider, Tim Friede, 2011
![Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis - ScienceDirect Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211034820303175-gr1.jpg)
Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis - ScienceDirect
![Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan | Scientific Reports Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-85321-3/MediaObjects/41598_2021_85321_Fig4_HTML.png)
Treatment outcomes of pediatric acute myeloid leukemia: a retrospective analysis from 1996 to 2019 in Taiwan | Scientific Reports
![Survival after relapse in childhood acute lymphoblastic leukemia - Gaynon - 1998 - Cancer - Wiley Online Library Survival after relapse in childhood acute lymphoblastic leukemia - Gaynon - 1998 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/1b1e5ec1-3d15-4344-9277-dd1d26e06c7e/mfig002.jpg)
Survival after relapse in childhood acute lymphoblastic leukemia - Gaynon - 1998 - Cancer - Wiley Online Library
![Overall and relapse-free survival rates in AML patients with no DMRGM,... | Download Scientific Diagram Overall and relapse-free survival rates in AML patients with no DMRGM,... | Download Scientific Diagram](https://www.researchgate.net/publication/303716743/figure/fig1/AS:484373641338881@1492495083612/Overall-and-relapse-free-survival-rates-in-AML-patients-with-no-DMRGM-one-DMRGM-and-two.png)
Overall and relapse-free survival rates in AML patients with no DMRGM,... | Download Scientific Diagram
![Predictors of five-year relapse rates of youths with substance abuse who underwent a family-oriented therapy program | Annals of General Psychiatry | Full Text Predictors of five-year relapse rates of youths with substance abuse who underwent a family-oriented therapy program | Annals of General Psychiatry | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12991-020-00269-4/MediaObjects/12991_2020_269_Fig2_HTML.png)
Predictors of five-year relapse rates of youths with substance abuse who underwent a family-oriented therapy program | Annals of General Psychiatry | Full Text
Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk | Haematologica
![Buprenorphine and methadone treatment among Medicaid members: Reducing relapse and health care costs – Recovery Research Institute Buprenorphine and methadone treatment among Medicaid members: Reducing relapse and health care costs – Recovery Research Institute](https://www.recoveryanswers.org/assets/Total-expenditure-cost-of-addiction-medications-length-of-treatment-Buprenorphine-Methadone-Treatment-Among-Medicaid-Members-Reducing-Relapse-Health-Care-Costs-Medicaid-Behavioral-health-Clark-Graph-1024x448.jpg)
Buprenorphine and methadone treatment among Medicaid members: Reducing relapse and health care costs – Recovery Research Institute
![Higher Graft T Cell and CD34 Cell Content Is Associated with Earlier Complete Chimerism, Lower Relapse Rates, and Improved Overall Survival (OS) in Recipients Undergoing Matched Related (MR) Myeloablative Hematopoietic Stem Cell Higher Graft T Cell and CD34 Cell Content Is Associated with Earlier Complete Chimerism, Lower Relapse Rates, and Improved Overall Survival (OS) in Recipients Undergoing Matched Related (MR) Myeloablative Hematopoietic Stem Cell](https://www.astctjournal.org/cms/asset/ee02f00c-684e-4001-a41b-c212f47bce66/gr7.jpg)